{"id":"cg5503-ir-tapentadol","safety":{"commonSideEffects":[{"rate":"15-25","effect":"Nausea"},{"rate":"10-20","effect":"Dizziness"},{"rate":"10-15","effect":"Somnolence"},{"rate":"5-10","effect":"Vomiting"},{"rate":"10-15","effect":"Constipation"},{"rate":"5-10","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tapentadol binds to mu-opioid receptors in the central nervous system to produce opioid-mediated analgesia, while simultaneously inhibiting the reuptake of norepinephrine, which enhances descending pain inhibitory pathways. This dual mechanism allows for effective pain relief with a potentially lower side effect profile compared to traditional opioids. CG5503 IR is an immediate-release formulation of tapentadol.","oneSentence":"Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms of action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:27.095Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain management"},{"name":"Moderate to severe pain"}]},"trialDetails":[{"nctId":"NCT01615510","phase":"PHASE1","title":"Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models","status":"TERMINATED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2012-10","conditions":"Pain, Hyperalgesia, Allodynia","enrollment":24},{"nctId":"NCT02081391","phase":"PHASE3","title":"A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2015-02-19","conditions":"Acute Pain","enrollment":216},{"nctId":"NCT00478023","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-05","conditions":"Hysterectomy, Postoperative","enrollment":854},{"nctId":"NCT00983073","phase":"PHASE3","title":"Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2009-09","conditions":"Chronic Pain, Osteoarthritis","enrollment":224},{"nctId":"NCT00982280","phase":"PHASE3","title":"Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.","status":"TERMINATED","sponsor":"Grünenthal GmbH","startDate":"2009-09","conditions":"Chronic Pain, Osteoarthritis","enrollment":82},{"nctId":"NCT03979989","phase":"PHASE1","title":"Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2005-09-28","conditions":"Pharmacokinetic","enrollment":32},{"nctId":"NCT00983385","phase":"PHASE3","title":"Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2009-09-30","conditions":"Chronic Pain, Low Back Pain","enrollment":208},{"nctId":"NCT01719601","phase":"","title":"A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain","status":"WITHDRAWN","sponsor":"Janssen Pharmaceutica","startDate":"2014-10","conditions":"Moderate to Severe Acute Non-Cancer Pain","enrollment":""},{"nctId":"NCT00594516","phase":"PHASE3","title":"Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2007-12","conditions":"Low Back Pain","enrollment":117},{"nctId":"NCT01813890","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2013-01","conditions":"Hallux Valgus","enrollment":60},{"nctId":"NCT00771758","phase":"PHASE3","title":"Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2008-09","conditions":"Back Pain","enrollment":108},{"nctId":"NCT01516008","phase":"PHASE3","title":"A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2012-01","conditions":"Hallux Valgus","enrollment":353},{"nctId":"NCT00364533","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety","status":"TERMINATED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-10","conditions":"Arthroplasty","enrollment":367},{"nctId":"NCT00986180","phase":"PHASE3","title":"NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2009-09","conditions":"Pain, Back Pain, Low Back Pain","enrollment":667},{"nctId":"NCT01500317","phase":"PHASE4","title":"Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-05","conditions":"Effects of 2 Mu-opiates on Gastrointestinal Transit","enrollment":38},{"nctId":"NCT00814580","phase":"PHASE3","title":"Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2008-12","conditions":"Postoperative Pain","enrollment":382},{"nctId":"NCT01545778","phase":"","title":"Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2010-02","conditions":"Substance Abuse Detection","enrollment":646620},{"nctId":"NCT00784277","phase":"PHASE3","title":"A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-10","conditions":"Joint Diseases, Arthritis, Osteoarthritis","enrollment":597},{"nctId":"NCT00609466","phase":"PHASE3","title":"A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-09","conditions":"Bunionectomy, Pain, Postoperative Pain","enrollment":291},{"nctId":"NCT00361582","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-10","conditions":"Osteoarthritis, Pain Assessment, Arthralgia","enrollment":669},{"nctId":"NCT00364546","phase":"PHASE3","title":"A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-07","conditions":"Osteoarthritis, Pain Intensity Assessment, Arthralgia","enrollment":877},{"nctId":"NCT00364247","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"","conditions":"Arthralgia, Bunion, Hallux Valgus","enrollment":602},{"nctId":"NCT00806247","phase":"PHASE2","title":"A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-01","conditions":"Pain, Postoperative Pain","enrollment":480}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CG5503 IR; tapentadol","genericName":"CG5503 IR; tapentadol","companyName":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","companyId":"johnson-johnson-pharmaceutical-research-development-l-l-c","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tapentadol is a mu-opioid receptor agonist and norepinephrine reuptake inhibitor that provides analgesia through dual mechanisms of action. Used for Acute pain management, Moderate to severe pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}